Martin G. Pomper, MD – FDA Inspection, May 25, 2018

Record Details

This FDA Inspection record concerns Martin G. Pomper, MD, with an inspection on May 25, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.

Company: Martin G. Pomper, MD
Inspection Date: May 25, 2018
Product Type: Drugs
Office: Center for Drug Evaluation and Research
Person: Ann B. Borromeo (Company Rep)

View Company Profile

ID · 993ad981-8a33-4a55-84cd-91b914514a6f

Inspection Facts

No Action Indicated (NAI)

No objectionable conditions or practices were found during the inspection.

Inspection number: 1053273
FDA center: Human Drugs
Project area: Bioresearch Monitoring
Outcome: Form 483 issued

FDA Citations

21 CFR 312.60FD-1572, protocol compliance

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Martin G. Pomper, MD

FDA Inspection

Martin G. Pomper, MDMay 25, 2018